Price
$4.54
Decreased by -12.36%
Dollar volume (20D)
49.25 M
ADR%
40.04
Earnings report date
Aug 7, 2025
Shares float
78.16 M
Shares short
14.03 M [17.95%]
Shares outstanding
129.54 M
Market cap
2.16 B
Beta
1.46
Price/earnings
N/A
20D range
0.54 7.13
50D range
0.54 7.13
200D range
0.46 7.13

ProKidney Corp., a clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States.

Its lead product candidate, rilparencel, includes autologous selected renal cells (SRC) in Phase 3 and Phase 2 clinical studies in subjects with moderate to severe chronic kidney disease and diabetes.

The company also develops a cryopreserved version of rilparencel that allows for long-term product preservation to be used in Phase 2 and 3 trials of rilparencel.

ProKidney Corp. was founded in 2015 and is headquartered in Winston-Salem, North Carolina.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
May 12, 25 -0.13
Increased by +18.75%
-0.16
Increased by +18.75%
Mar 17, 25 -0.16
Decreased by -77.78%
-0.15
Decreased by -6.67%
Nov 10, 24 -0.14
Increased by +21.17%
-0.15
Increased by +5.40%
Aug 9, 24 -0.16
Decreased by -14.29%
-0.17
Increased by +5.88%
May 10, 24 -0.16
Increased by 0.00%
-0.18
Increased by +11.11%
Mar 22, 24 -0.09
Increased by +18.18%
-0.17
Increased by +47.06%
Nov 14, 23 -0.18
Decreased by -38.46%
-0.16
Decreased by -12.50%
Aug 10, 23 -0.14
Decreased by -150.90%
-0.39
Increased by +64.10%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Mar 31, 25 230.00 K
Increased by +N/A%
-16.73 M
Decreased by -76.30%
Decreased by -7.28 K%
Decreased by N/A%
Dec 31, 24 76.00 K
Decreased by -98.31%
-21.28 M
Decreased by -273.23%
Decreased by -28.00 K%
Decreased by -21.97 K%
Sep 30, 24 0.00
Decreased by N/A%
-17.91 M
Decreased by -63.06%
Decreased by N/A%
Decreased by N/A%
Jun 30, 24 0.00
Decreased by N/A%
-12.51 M
Decreased by -37.16%
Decreased by N/A%
Decreased by N/A%
Mar 31, 24 0.00
Decreased by N/A%
-9.49 M
Increased by +1.79%
Decreased by N/A%
Decreased by N/A%
Dec 31, 23 4.49 M
Increased by +N/A%
-5.70 M
Increased by +76.80%
Decreased by -126.86%
Decreased by N/A%
Sep 30, 23 0.00
Decreased by N/A%
-10.98 M
Increased by +7.91%
Decreased by N/A%
Decreased by N/A%
Jun 30, 23 0.00
Decreased by -100.00%
-9.12 M
Increased by +58.80%
Decreased by N/A%
Decreased by N/A%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY